GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » ROE % Adjusted to Book Value

Pro Medicus (ASX:PME) ROE % Adjusted to Book Value : 0.77% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus ROE % Adjusted to Book Value?

Pro Medicus's ROE % for the quarter that ended in Dec. 2023 was 48.66%. Pro Medicus's PB Ratio for the quarter that ended in Dec. 2023 was 62.88. Pro Medicus's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 0.77%.


Pro Medicus ROE % Adjusted to Book Value Historical Data

The historical data trend for Pro Medicus's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus ROE % Adjusted to Book Value Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.92 0.58 1.12 1.02

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 1.12 1.01 1.06 0.77

Competitive Comparison of Pro Medicus's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Pro Medicus's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pro Medicus's ROE % Adjusted to Book Value falls into.



Pro Medicus ROE % Adjusted to Book Value Calculation

Pro Medicus's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=50.43% / 49.39
=1.02%

Pro Medicus's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=48.66% / 62.88
=0.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pro Medicus's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.